What Вита Мелатонин Treats: Main Uses and Benefits

Vita Melatonin is relevant in areas where additional symptomatic support is needed for conditions related to the body's sleep-wake timing and rhythm. The medication may assist with conditions such as jet lag and delayed sleep-wake phase disorder (DSWPD), contributing to easing the overall symptom load.

It is commonly used to help manage symptom clusters that create noticeable functional strain, particularly difficulty falling asleep (prolonged sleep onset latency) and fragmented sleep. The medication is also applied in specific patient contexts, including support for older adults with age-related sleep disturbances and individuals with sleep problems linked to neurodevelopmental conditions.

The overall benefit is supportive, where it: “assists with maintaining functional stability; it may contribute to a more consistent sleep duration and improves comfort during periods of heightened symptoms.” This symptomatic relief helps patients cope more steadily with these difficult nocturnal episodes.

---

Quick Fact: Support for Sleep Timing
Primary Use Focus	Symptoms linked to sleep timing
Symptoms Addressed	Difficulty falling asleep, frequent nocturnal awakenings
Common Scenarios	Jet lag, shift work, DSWPD
Benefit	Contributes to improved comfort and supports general well-being during symptomatic phases

---

Regulatory References

1. NIH National Center for Complementary and Integrative Health

The eligibility for using Вита Мелатонин is strictly defined by official regulatory labeling, focusing on age and specific health conditions.

Populations Allowed and Excluded

Classification	Eligible Groups (Official Use)	Excluded Groups (Contraindications & Restrictions)
Age Groups	Adults; older adults (ge 55 years); Children and adolescents (6–17) with specific neurodevelopmental conditions.	Children under 6 years (use not established); General use in adolescents under 18 (not recommended).
Health Status	General adult population with defined short-term sleep disturbances.	Patients with known hypersensitivity to the ingredient; Individuals with autoimmune diseases; Those with moderate or severe hepatic impairment.
Reproductive Status	None (Use not recommended).	Women who are pregnant; Women who are breastfeeding; Women of childbearing potential not using effective contraception.

Regulatory documents mandate caution or restricted use in patients with renal impairment or epilepsy. The official eligibility framework is primarily established for adults and certain conditional patient groups, explicitly excluding or strongly restricting use based on specific comorbidities and reproductive states.

Interactions with other medicines and products

The official interaction profile for Melatonin (Вита Мелатонин) is defined by pharmacokinetic and pharmacodynamic constraints documented in government regulatory labeling. This structure highlights substances that formally contraindicate or require avoidance of co-administration.

Formal Restrictions and Avoided Combinations. The co-administration of Melatonin with certain substances is officially restricted. Combinations with the potent CYP1A2 inhibitor Fluvoxamine are advised to be avoided due to a documented, severe increase in Melatonin exposure (up to 17-fold AUC). The product is also formally advised against use with Benzodiazepine and Non-benzodiazepine hypnotics (e.g., Zolpidem) due to enhanced sedative properties. Use with alcohol is formally not recommended as it reduces the effectiveness of the medicine on sleep, and the combination with Warfarin should be avoided.

Metabolism and Exposure Alterations. Melatonin's metabolism is primarily mediated by CYP450 enzymes, chiefly CYP1A2 and CYP2C19. Substances that inhibit this pathway, such as Cimetidine and Oestrogens, are documented to increase Melatonin's plasma concentration. Conversely, CYP1A2 inducers like Rifampicin, Carbamazepine, and Cigarette Smoking may reduce plasma levels by accelerating clearance.

Timing and Pharmacodynamic Constraints. The regulatory profile includes mandatory timing requirements. Melatonin is recommended to be taken at least two hours before and two hours after a meal. Furthermore, Beta-blockers are advised to be administered in the morning, and NSAIDs should be avoided in the evening, as both classes may suppress endogenous Melatonin levels, according to regulatory documents.

How Вита Мелатонин Works

Targeting Central Circadian Rhythm Receptors ( MT1 and MT2)

Вита Мелатонин exerts its primary pharmacodynamic effect as a direct agonist by engaging specific G-protein coupled melatonin receptors, namely the MT1 and MT2 subtypes. These receptors are centrally located within the Suprachiasmatic Nucleus (SCN) of the hypothalamus. This receptor-mediated action initiates a neural signaling cascade crucial for modulating the body's master clock, which directly influences the neural signaling patterns associated with the initiation of sleep.

Influencing Downstream Physiological Cascades

Beyond central receptor binding, the resulting activity influences a cascade of downstream physiological changes. This mechanistic domain involves the modulation of key regulatory systems, such as subtly influencing core body temperature and hormonal release patterns, resulting in the modulation of systemic physiological parameters that accompany the rest phase.

Dual-Action Cellular Antioxidant Mechanism

A secondary but significant mechanistic domain involves broad-spectrum, non-receptor antioxidant activity. Вита Мелатонин acts both as a direct free radical scavenger and an indirect activator of key protective enzymes, engaging mechanisms that facilitate the neutralization of reactive oxygen and nitrogen species at the cellular level.

How to Use Melatonin

The administration of melatonin is governed by the specific formulation, which is primarily via the oral route. Instructions are defined by the intended clinical use and the type of tablet (immediate-release or prolonged-release).

---

Official Dosing and Frequency

Clinical Context	Recommended Dose	Frequency	Duration Pattern
Primary Insomnia (ge 55 years)	2 mg (prolonged-release)	Once daily	Short-term, typically up to 13 weeks
Jet Lag	3 mg (immediate-release), max 6 mg	Once daily	Max 5 days per course, limited to 16 courses/year

---

Administration Conditions and Procedural Rules

Administration timing is critical for the medicine's effect. The prolonged-release tablet is instructed to be taken 1 to 2 hours before bedtime and after food to ensure its intended release profile. Conversely, immediate-release tablets for jet lag should be taken at the habitual bedtime upon arrival, ensuring the dose is separated from food by at least two hours.

Procedural guidelines stipulate that prolonged-release tablets must be swallowed whole with fluid and must not be crushed, chewed, or divided. For jet lag, use is restricted to a specific time window, generally not before 20:00 hr or after 04:00 hr (at destination time), to maintain the drug's synchronizing function.

High-level usage instructions further specify that the medicine is not recommended for patients with severe liver or kidney impairment.

Recent Clinical Evidence Overview

Clinical research on melatonin, the active substance, has primarily focused on its role in circadian rhythm sleep disorders and insomnia. The evidence suggests it may reduce the time required to fall asleep, known as sleep onset latency, particularly in certain populations.

---

Primary Research Areas

Clinical trials and meta-analyses have investigated melatonin's use across several sleep-related conditions:

• Primary Insomnia: Studies examining melatonin's effect on chronic insomnia show mixed results regarding overall sleep quality and total sleep duration. However, some evidence suggests a slight reduction in sleep onset latency (the time it takes to fall asleep), especially in older adults (aged 55 and over) who may have lower natural melatonin production.
• Jet Lag: Research indicates that melatonin may help reset the body's internal clock, which can reduce the symptoms of jet lag, particularly following travel across five or more time zones. It may aid in re-establishing the desired sleep-wake cycle at the destination.
• Delayed Sleep-Wake Phase Disorder (DSWPD): For both children and adults with DSWPD, multiple studies have shown that melatonin can advance the timing of the sleep cycle, helping individuals fall asleep earlier.

---

Safety and Interpretation

Melatonin is generally considered well-tolerated for short-term use in clinical settings, with reported side effects typically being mild, such as headache or daytime drowsiness. However, authoritative bodies caution that the benefits of long-term use are not fully established, and its classification as a dietary supplement in some regions means the content and quality can vary significantly. Clinicians advise that cognitive behavioral therapy for insomnia (CBT-I) remains the initial treatment recommendation for chronic insomnia.

Common questions about Вита Мелатонин (FAQ)

Q: What is Вита Мелатонин (Vita Melatonin) and how is it used?

Вита Мелатонин is a medication containing the active ingredient melatonin, which is a hormone naturally produced by the pineal gland in the brain. It is primarily used to help regulate the sleep-wake cycle (circadian rhythm).

It is commonly used to treat insomnia (difficulty falling or staying asleep), particularly in people over 55 who have poor sleep quality. It is also sometimes used to help with jet lag and shift work sleep disorder.

Q: How should I take Вита Мелатонин?

The correct dosage and timing depend on your specific condition and should be determined by a healthcare provider. Melatonin is usually taken orally as a tablet or capsule.

For sleep-related issues, it is typically taken 30 minutes to 2 hours before bedtime. It's important to take it at the same time each day to help reset your body's sleep clock. Avoid consuming alcohol close to when you take the medication, as this can affect its efficacy and increase potential side effects.

Q: Can I use Вита Мелатонин for long-term insomnia?

Melatonin is often used for short-term treatment of primary insomnia, which is sleep difficulty that is not due to another medical or psychological cause. The safety and effectiveness of long-term use (more than 13 weeks) are less established, especially in specific populations.

If you have chronic insomnia, it is important to discuss the cause of your sleep problems with a doctor. They may recommend combining medication with non-pharmacological treatments like cognitive behavioral therapy for insomnia (CBT-I).

Q: What are the common side effects of Вита Мелатонин?

Common side effects of melatonin are usually mild and may include:

• Headache
• Dizziness
• Nausea or upset stomach
• Drowsiness or excessive sleepiness, especially the morning after taking it

Because melatonin can cause drowsiness, it is recommended to avoid driving or operating heavy machinery for four to five hours after taking the medication.

Q: Are there any serious side effects or warnings I should know about?

While serious side effects are rare, you should seek medical attention if you experience signs of an allergic reaction (such as rash, swelling of the face, tongue, or throat) or if you notice changes in mood, such as increased depression or anxiety.

It should be used with caution in individuals with certain pre-existing conditions, including epilepsy, autoimmune diseases, and liver or kidney impairment. Always inform your doctor of your complete medical history before starting treatment.

Q: Does Вита Мелатонин interact with other medications?

Yes, melatonin can interact with several types of medications, potentially changing their effects or increasing the risk of side effects. Key interactions include:

• Anticoagulants (blood thinners) and antiplatelet drugs: Melatonin may increase the risk of bleeding.
• Sedatives and sleep medications: Taking it with other medicines that cause drowsiness can increase sedation.
• Antidepressants and anticonvulsants.
• Immunosuppressants: Melatonin might reduce their effectiveness.
• Caffeine and alcohol: These substances can interfere with the drug's effects.

It is essential to provide your healthcare provider with a complete list of all prescription, over-the-counter, and herbal supplements you are taking.

How to Store and Dispose of Melatonin

The storage and disposal of melatonin must strictly follow regulatory guidance to maintain product stability and ensure public safety.

Official Storage Requirements

The product must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Storage is required to be in a cool, dry place, and the medicine must be protected from excessive heat, moisture, and light. To preserve integrity, the medicine must be kept in its original container with the seal intact.

Child Safety and Disposal

It is a mandatory requirement to store the medication strictly out of the sight and reach of children.

Disposal of any unused or expired product must be carried out according to local regulations. Medicines should not be disposed of via household trash or wastewater to protect the environment.